Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Psychol Med. 2009 Jun 17;40(2):225. doi: 10.1017/S0033291709990213

Table 1.

Thirty-day, 12-month, and lifetime prevalence estimates of DSM-IV/CIDI MDE by age and gender

Age Groups
Age
Difference
All ages 18-34 35-49 50-64 65+
% (se) % (se) % (se) % (se) % (se) χ23

I. Total
 30-day 3.1 (0.2) 3.7 (0.3) 3.7 (0.3) 3.0 (0.4) 1.0 (0.3) 46.9*
 12-month 8.3 (0.3) 10.4 (0.5) 9.4 (0.5) 7.7 (0.7) 2.6 (0.4) 103.5*
 Lifetime 19.2 (0.5) 19.4 (0.8) 22.7 (0.9) 20.7 (1.2) 9.8 (0.9) 70.4*
  (n) (9,282) (3,033) (2,865) (1,922) (1,461)
II. Females
 30-day 3.9 (0.2) 5.0 (0.5) 4.5 (0.4) 3.3 (0.5) 1.5 (0.5) 24.1*
 12-month 10.2 (0.5) 13.6 (0.8) 11.3 (0.6) 9.1 (1.0) 3.7 (0.7) 63.3*
 Lifetime 22.9 (0.6) 23.7 (1.1) 26.7 (1.0) 24.6 (1.5) 13.0 (1.3) 40.8*
  (n) (5,143) (1,658) (1,522) (1,068) (894)
III. Males
 30-day 2.3 (0.2) 2.4 (0.4) 2.9 (0.5) 2.8 (0.5) 0.2 (0.2) 49.2*
 12-month 6.2 (0.4) 7.2 (0.7) 7.4 (0.8) 6.1 (0.9) 1.2 (0.5) 90.7*
 Lifetime 15.1 (0.8) 15.1 (1.2) 18.6 (1.4) 16.2 (1.4) 5.3 (1.2) 132.1*
  (n) (4139) (1375) (1343) (854) (567)